In the year 2020, many of South Korean pharmaceutical companies turned their eyes on new potential businesses. They reported major M&A news more than before. Some of them also took a bold step into bio company investment to find new opportunities.

◆GC and Celltrion ink notable M&A deals in hopes of finding new lucrative businesses

The industry paid a close attention on GC as it delivered the news of finalizing two big M&A deals.

GC Healthcare paid 208.8 billion won in last February to acquire an IT company UB Care. GC Healthcare is a subsidiary of GC that provides customized healthcare service based on IT.

UB Care is South Korea’s number one electroni